{"id":"W3011470625","doi":"10.1016/j.eururo.2019.09.035","title":"EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Cilag; Sanofi Pasteur; Pharmacyclics; Chugai Pharmaceutical; Genentech; European Association of Urology; European Society for Medical Oncology; Astellas Pharma; Eisai; Bayer; Universitat Autònoma de Barcelona; Cancer Research UK; GlaxoSmithKline; UroGen Pharma; MSD Australia; EMD Serono; Radboud Universitair Medisch Centrum; Pfizer; Incyte; Medac; Ipsen; Clovis Oncology; Alere; Bayer HealthCare; Sanofi; Amgen; Radboud Universiteit; Novartis; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Consensus conference; Bladder cancer; MEDLINE; Family medicine; Urology; General surgery; Oncology; Cancer; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001584485,0.0001464166,0.0001881691,0.00005014357,0.00004232101,0.000009601731,0.0001128551,0.00002358587,0.0005940236],"category_scores_gemma":[0.000007017682,0.00009897742,0.00002644686,0.00007764274,0.0001068618,0.00003978275,0.00006243196,0.0001068777,0.00006944224],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003412668,"about_ca_system_score_gemma":0.00003405352,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004218845,"about_ca_topic_score_gemma":0.00001352603,"domain_scores_codex":[0.9989806,0.000138148,0.0002227062,0.0003087669,0.0001779624,0.0001717531],"domain_scores_gemma":[0.9993789,0.00004745714,0.0001190397,0.0002919567,0.00009638399,0.00006621933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04923218,0.007932373,0.4152051,0.0009871966,0.03466279,0.008618267,0.02485428,0.005886428,0.02549222,0.1218829,0.01671669,0.2885295],"study_design_scores_gemma":[0.01484488,0.00384476,0.8768343,0.0001154082,0.0004855803,0.00005939898,0.001354802,0.0004460143,0.001075466,0.0001393125,0.1005215,0.0002786672],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9338018,0.0001506673,0.00002059828,0.001802672,0.0005102049,0.0008253899,0.0001204823,0.0000228114,0.06274541],"genre_scores_gemma":[0.9949311,0.0002625188,0.0003548343,0.002081527,0.00004857131,0.00002751169,0.00003006022,0.00002971369,0.002234155],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4616291,"threshold_uncertainty_score":0.6504141,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02578443331298604,"score_gpt":0.3183087991993905,"score_spread":0.2925243658864045,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}